Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,985 | -45,318 | -51,790 | -3,038 | -1,697 |
| Depreciation Amortization | 9 | 10 | 4 | 2 | 1 |
| Accounts payable and accrued liabilities | -3,877 | 3,755 | 6,639 | 463 | -282 |
| Other Working Capital | -4,398 | 4,672 | 8,115 | 350 | -293 |
| Other Operating Activity | 3,810 | 31,914 | 38,836 | -462 | 282 |
| Operating Cash Flow | $-7,441 | $-4,966 | $1,805 | $-2,686 | $-1,989 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -11 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 1,402 | 1,411 | 0 | 0 |
| Investing Cash Flow | $-42 | $1,392 | $1,411 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,031 | 3,031 | N/A | N/A |
| Debt Repayment | N/A | -3,561 | -509 | -509 | N/A |
| Common Stock Issued | N/A | 75,000 | 75,000 | N/A | N/A |
| Other Financing Activity | 0 | -5,426 | -5,418 | 0 | 0 |
| Financing Cash Flow | $N/A | $69,044 | $72,104 | $-509 | $N/A |
| Exchange Rate Effect | -7 | 122 | 126 | 69 | -10 |
| Beginning Cash Position | 68,920 | 3,328 | 3,328 | 3,328 | 3,328 |
| End Cash Position | 61,430 | 68,920 | 78,773 | 201 | 1,329 |
| Net Cash Flow | $-7,491 | $65,593 | $75,445 | $-3,126 | $-1,999 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,441 | -4,966 | 1,805 | -2,686 | -1,989 |
| Capital Expenditure | -42 | -11 | N/A | N/A | N/A |
| Free Cash Flow | -7,483 | -4,976 | 1,805 | -2,686 | -1,989 |